Rein Therapeutics Inc (RNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RNTX | AZN | AMGN | GILD | BMY |
| Company | Rein Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.1000 | 185.45 | 332.52 | 130.00 | 60.02 |
| High | 1.1000 | 187.18 | 337.00 | 132.14 | 60.09 |
| Low | 1.0000 | 184.01 | 324.63 | 129.01 | 58.03 |
| Latest | 1.0100 | 185.48 | 328.49 | 132.02 | 58.69 |
| Change | -0.3450 | -1.89 | -17.76 | +1.18 | -1.90 |
| % Change | -25.46% | -1.01% | -5.13% | +0.90% | -3.14% |
| Volume | 8,796,369 | 1,268,357 | 2,285,053 | 2,236,033 | 9,979,662 |
| 20-Day Average Volume | 631,478 | 2,006,438 | 2,476,064 | 5,170,381 | 9,385,810 |
| Previous Close | 1.3550 | 187.37 | 346.25 | 130.84 | 60.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5825 | 196.75 | 345.89 | 135.58 | 58.77 |
| 20-Day Raw Stochastic | 1.82% | 12.63% | 6.78% | 27.17% | 40.17% |
| 20-Day Relative Strength | 36.70 | 39.72 | 37.11 | 41.57 | 49.32 |
| Weighted Alpha | -23.10 | +23.82 | +12.23 | +22.50 | +20.94 |
| Today's Opinion | 8% Buy | 24% Buy | 8% Sell | 8% Buy | 40% Buy |
| Previous Opinion | 64% Buy | 40% Buy | 8% Buy | Hold | 72% Buy |
| Last Month's Opinion | 80% Sell | 80% Buy | 40% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -38.55% since 04/24/26 | -2.52% since 04/24/26 | -5.10% since 04/24/26 | +1.08% since 04/24/26 | -0.10% since 04/24/26 |
| Low | 1.0000 on 05/01/26 | 181.73 on 04/29/26 | 324.63 on 05/01/26 | 127.64 on 04/27/26 | 57.28 on 04/29/26 |
| High | 1.6800 on 04/27/26 | 190.59 on 04/27/26 | 349.54 on 04/30/26 | 132.21 on 04/30/26 | 60.78 on 04/30/26 |
| 1-Month | |||||
| %Chg | -15.70% since 04/01/26 | -7.86% since 04/01/26 | -7.44% since 04/01/26 | -6.05% since 04/01/26 | -4.99% since 04/01/26 |
| Low | 1.0000 on 05/01/26 | 181.73 on 04/29/26 | 324.63 on 05/01/26 | 127.64 on 04/27/26 | 57.22 on 04/15/26 |
| High | 2.1000 on 04/22/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | -21.54% since 01/30/26 | -0.31% since 01/30/26 | -4.36% since 01/30/26 | -7.15% since 01/30/26 | +6.54% since 01/30/26 |
| Low | 1.0000 on 05/01/26 | 181.73 on 04/29/26 | 324.63 on 05/01/26 | 127.64 on 04/27/26 | 54.96 on 02/02/26 |
| High | 2.1000 on 04/22/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -34.82% since 10/31/25 | +12.23% since 10/31/25 | +9.57% since 10/31/25 | +10.03% since 10/31/25 | +27.31% since 10/31/25 |
| Low | 1.0000 on 05/01/26 | 160.96 on 11/04/25 | 292.12 on 11/03/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 2.1800 on 11/03/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 37,993 | 290,593,632 | 186,865,936 | 162,401,488 | 123,708,720 |
| Shares Outstanding, K | 28,039 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -49,870,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -31,970,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.40 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.36 on 03/26/26 | 2.12 on 02/10/26 | 5.15 on 04/30/26 | 1.86 on 02/10/26 | 1.58 on 04/30/26 |
| Earnings Date | 05/21/26 | 08/04/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.00 | 15.47 | 15.81 | 9.36 |